Literature DB >> 7251169

Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

I Azuma, H Okumura, I Saiki, Y Tanio, M Kiso, A Hasegawa, Y Yamamura.   

Abstract

The 6-amino-6-deoxy-N-acetylmuramyldipeptides and their 6-acylamino derivatives were shown to be active as adjuvants on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-l-tyrosine in guinea pigs. However, 6-acylamino-6-deoxy-N-(acyl)muramyldipeptides were inactive as adjuvants.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251169      PMCID: PMC351595          DOI: 10.1128/iai.32.3.1305-1308.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers.

Authors:  A Adam; M Devys; V Souvannavong; P Lefrancier; J Choay; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1976-09-07       Impact factor: 3.575

2.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

3.  Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).

Authors:  F Audibert; L Chedid; P Lefrancier; J Choay; E Lederer
Journal:  Ann Immunol (Paris)       Date:  1977 Apr-Jun

4.  Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine.

Authors:  Y Yamamura; I Azuma; K Sugimura; M Yamawaki; M Uemiya
Journal:  Gan       Date:  1976-12

5.  Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.

Authors:  I Azuma; K Sugimura; T Taniyama; M Yamawaki; Y Yamamura
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

6.  Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.

Authors:  A Tanaka; R Saito; K Sugiyama; I Morisaki; S Kotani
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

7.  The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.

Authors:  S Kotani; Y Watanabe; F Kinoshita; I Morisaki; K Kato
Journal:  Biken J       Date:  1977-06

8.  Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; F Kinoshita; T Shimono; I Morisaki
Journal:  Biken J       Date:  1975-06

9.  Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.

Authors:  S Kotani; F Kinoshita; I Morisaki; T Shimono; T Okunaga; H Takada; M Tsujimoto; Y Watanabe; K Kato; T Shiba; S Kusumoto; S Okada
Journal:  Biken J       Date:  1977-12

10.  In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice.

Authors:  C Damais; M Parant; L Chedid; P Lefrancier; J Choay
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

View more
  2 in total

1.  Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; H Okumura; I Saiki; M Kiso; A Hasegawa; Y Tanio; Y Yamamura
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

2.  Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors.

Authors:  S Tsuji; M Matsumoto; O Takeuchi; S Akira; I Azuma; A Hayashi; K Toyoshima; T Seya
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.